Myriad case on Feb. 2 in SD NY

The headline at USAToday on Feb. 2's Myriad case in SD NY was Medical groups assail patenting of human genes and there was text:

The suit is supported by groups such as the American Medical Association, the March of Dimes and the American Society for Human Genetics. It also argues that gene patents make research into tests and cures for cancer more difficult by requiring researchers to obtain licenses from the patent holder.

The Wall Street Journal included text on Myriad's position:

However, Brian Poissant, a lawyer for Myriad and the research foundation directors, argued that the patents aren't to human genes themselves but to isolated DNA molecules and methods for diagnosing cancer using those molecules.

"This is not nature's handiwork," Poissant said Tuesday. "This is the ingenuity of man."

See previous IPBiz post:
LA Times editorial opposes Myriad position in BRCA case on policy grounds

See also

Bioethics and Patent Law: The Case of Myriad from the wipo website